학술논문

yyEfficacy of immune-checkpoint inhibitor (ICI) combination as a first-line (1L) therapy in metastatic renal cell carcinoma (mRCC) with sarcomatoid histology: A systematic review and meta-analysis.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 20 2023, 41 1p. Supplement: 6
Subject
Language
English
ISSN
15277755